The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; Roche/Genentech; Sanofi/Aventis
Consulting or Advisory Role - Amgen; Celgene; Roche/Genentech; Sanofi/Aventis
Research Funding - Bayer (Inst)
Travel, Accommodations, Expenses - Amgen; Roche/Genentech
HepaVac-101 first-in-man therapeutic cancer vaccine phase I/II clinical trial for hepatocellular carcinoma patients.
 
Luigi Buonaguro
No Relationships to Disclose
 
Andrea Mayer-Mokler
Employment - Immatics
Stock and Other Ownership Interests - Immatics
Travel, Accommodations, Expenses - Immatics
 
Roberto Accolla
No Relationships to Disclose
 
Yuk Ting Ma
Honoraria - Bayer
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Merck Serono (Inst)
Travel, Accommodations, Expenses - Bayer
 
Regina Heidenreich
Employment - CureVac
Patents, Royalties, Other Intellectual Property - CureVac
 
Antonio Avallone
No Relationships to Disclose
 
Ester Simeone
No Relationships to Disclose
 
Alfred Koenigsrainer
No Relationships to Disclose
 
Markus Loeffler
No Relationships to Disclose
 
Cecile Gouttefangeas
Research Funding - Boehringer Ingelheim; RhoVac
Patents, Royalties, Other Intellectual Property - Univ. Tubingen
 
Christian Flohr
Employment - Immatics
Leadership - Immatics
Stock and Other Ownership Interests - Immatics
Travel, Accommodations, Expenses - Immatics
 
Joerg Ludwig
Employment - Immatics
 
Hans-Georg Rammensee
Leadership - CureVac; Immatics; Synarc
Stock and Other Ownership Interests - CureVac; Immatics; Synarc
Consulting or Advisory Role - CureVac; Immatics; Synarc
Research Funding - Boehringer Ingelheim; CeGaT; Miltenyi Biotec
Patents, Royalties, Other Intellectual Property - CureVac; Immatics; Univ Tubingen
Travel, Accommodations, Expenses - AstraZeneca; CureVac; Immatics
 
Mercedes Iñarrairaegui
Speakers' Bureau - Bayer
 
Sven Francque
No Relationships to Disclose
 
Tanguy Chaumette
No Relationships to Disclose
 
Toni Weinschenk
Employment - Immatics
Leadership - Immatics
Stock and Other Ownership Interests - Immatics
 
Carsten Reinhardt
Employment - Immatics
Leadership - Immatics
Stock and Other Ownership Interests - Immatics
 
Senta Ulrike Gnad-Vogt
Employment - CureVac
Leadership - CureVac
Stock and Other Ownership Interests - Bristol-Myers Squibb
Honoraria - CureVac
Patents, Royalties, Other Intellectual Property - CureVac
 
Harpreet Singh
Employment - Immatics
Leadership - Immatics
Stock and Other Ownership Interests - Immatics